Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Other Non-Current Liabilities (2011 - 2019)

Updated

Vistagen Therapeutics' Other Non-Current Liabilities was $381,100 in fiscal Q4 2019 (quarter ended Mar 31, 2019), up 33.4% from $285,600 a year earlier but down 4.7% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Other Non-Current Liabilities (2011 - 2019) Analysis & Trends

From fiscal Q4 2011 onward, Vistagen Therapeutics has reported Other Non-Current Liabilities for 20 quarters.

  • Other Non-Current Liabilities has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 31.4% (FY2014 to FY2019).
  • In earlier fiscal years, Other Non-Current Liabilities was $285,600 in FY2018 (+105.2%), $139,200 in FY2017 (+150.8%), $55,500 in FY2016 (-98.2%) and $3.01 million in FY2015.
  • Quarterly Other Non-Current Liabilities has moved between $55,500 (fiscal Q4 2016) and $3.01 million (fiscal Q4 2015) over five years.
  • Compared with a year earlier, Other Non-Current Liabilities has increased for six straight quarters, with growth averaging 89.1% over the last six quarters.
  • The best year-over-year quarter for Other Non-Current Liabilities over five years was fiscal Q3 2018 (growth of 294.1%); the worst was fiscal Q4 2016 (a decline of 98.2%).
  • Per Business Quant data, VTGN's Other Non-Current Liabilities in the three fiscal quarters before Q4 2019 was $399,800 (Q3 2019), $418,500 (Q2 2019) and $272,000 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 381,100.00
Dec 31, 2018 399,800.00
Sep 30, 2018 418,500.00
Jun 30, 2018 272,000.00
Mar 31, 2018 285,600.00
Dec 31, 2017 299,100.00
Sep 30, 2017 312,700.00
Jun 30, 2017 202,500.00
Mar 31, 2017 139,200.00
Dec 31, 2016 75,900.00
Mar 31, 2016 55,500.00
Mar 31, 2015 3.01 Mn
Jun 30, 2014 95,900.00
Mar 31, 2014 97,400.00
Dec 31, 2013 97,300.00
Sep 30, 2013 81,400.00
Mar 31, 2013 97,400.00
Dec 31, 2012 3.91 Mn
Sep 30, 2012 1.44 Mn
Mar 31, 2011 417,100.00
API Access

Vistagen Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=VTGN&period=max&api_key=YOUR_API_KEY